Jinjun Wu

1.4k citations
39 papers · 1.1k indexed · h-index 19

Impact in

Papers in

Jinjun Wu

37 papers receiving 1.1k citations

Peers

Jinjun Wu
Comparison fields: 5 of 90
  • Pharmacology 353
  • Complementary and alternative medicine 190
  • Pharmacology 190
  • Cancer Research 129
  • Molecular Biology 513
Replace Zhongxiang Zhao with:
Zhongxiang Zhao China
Chun-Feng Zhang China
Yingjie Wei China
Ding‐Qiao Xu China
Xiaohui Wei China
Runzhi Zhang China
Yihang Shen China
Shi Sun United States
Tai Rao China
Jinjun Wu relative to Zhongxiang Zhao China Zhongxiang Zhao's profile →
Citations per field
00.5×1.5×
Zhongxiang Zhao · 1×
Citations per year

Countries citing papers authored by Jinjun Wu

Since Specialization
Citations

This map shows the geographic impact of Jinjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinjun Wu more than expected).

Fields of papers citing papers by Jinjun Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinjun Wu. The network helps show where Jinjun Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Jinjun Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jinjun Wu Line = papers co-authored together Jinjun Wu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019123
2 2016105
3 201891
4 201976
5 202049
6 201646
7 202144
8 201643
9 201543
10 201839
11 202336
12 201633
13 201632
14 201731
15 201630
16 201729
17 201420
18 202119
19 202118
20 202118

About Jinjun Wu

Jinjun Wu is a scholar working on Pharmacology, Pharmacology, Complementary and alternative medicine, Cancer Research and Toxicology, having authored 39 papers that have together received 1.1k indexed citations. Recurring topics across this work include Plant-based Medicinal Research (11 papers), Berberine and alkaloids research (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Traditional Chinese Medicine Analysis (5 papers), Natural product bioactivities and synthesis (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer-related molecular mechanisms research (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). The work is most often cited by research in Pharmacology (353 citations), Complementary and alternative medicine (190 citations), Pharmacology (190 citations), Cancer Research (129 citations) and Molecular Biology (513 citations). Jinjun Wu has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Zhongqiu Liu, Yanmei Lou, Linlin Lu, Muyan Kong, Zhenzhen Guo, Guiyu Zhang, Yuanfeng Zhu, Fangyuan Li, Zhongqiu Liu and Leyan Li. Their work appears in journals such as Journal of Ethnopharmacology, Molecules, Phytomedicine, Frontiers in Pharmacology and Chinese Journal of Natural Medicines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026